To address this, we first knocked down HMGA2 in two thyroid cancer derived cell lines: TPC-1 cells, derived from a RET/PTC1 positive PTC, and BCPAP cells, originating from a BRAFV600E positive poorly differentiated PTC. This evidence concerns the gene RET and thyroid cancer.